TJP1 and colorectal cancer: Early studies analyzing biopsies from colorectal cancer demonstrated that the level of ZO-1 is frequently reduced in primary colorectal cancer as compared to the normal epithelium in patients with liver metastasis (20.8%); furthermore, ZO-1 is often re-expressed in liver metastasized cancers (79.2%) [28].